118 related articles for article (PubMed ID: 8552410)
1. Isotype-specific characterization of antibody responses to Onchocerca volvulus in putatively immune individuals.
Stewart GR; Elson L; Araujo E; Guderian R; Nutman TB; Bradley JE
Parasite Immunol; 1995 Jul; 17(7):371-80. PubMed ID: 8552410
[TBL] [Abstract][Full Text] [Related]
2. The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.
Cho-Ngwa F; Liu J; Lustigman S
PLoS Negl Trop Dis; 2010 Aug; 4(8):e800. PubMed ID: 20808763
[TBL] [Abstract][Full Text] [Related]
3. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
[TBL] [Abstract][Full Text] [Related]
4. Immunity to onchocerciasis: identification of a putatively immune population in a hyperendemic area of Ecuador.
Elson LH; Guderian RH; Araujo E; Bradley JE; Days A; Nutman TB
J Infect Dis; 1994 Mar; 169(3):588-94. PubMed ID: 8158031
[TBL] [Abstract][Full Text] [Related]
5. Human onchocerciasis in Nigeria: isotypic responses and antigen recognition in individuals with defined cutaneous pathology.
Murdoch ME; Abiose A; Garate T; Hay RJ; Jones BR; Maizels RM; Parkhouse RM
Am J Trop Med Hyg; 1996 Jun; 54(6):600-12. PubMed ID: 8686779
[TBL] [Abstract][Full Text] [Related]
6. Specific and sensitive IgG4 immunodiagnosis of onchocerciasis with a recombinant 33 kD Onchocerca volvulus protein (Ov33).
Lucius R; Kern A; Seeber F; Pogonka T; Willenbücher J; Taylor HR; Pinder M; Ghalib HW; Schulz-Key H; Soboslay P
Trop Med Parasitol; 1992 Sep; 43(3):139-45. PubMed ID: 1281926
[TBL] [Abstract][Full Text] [Related]
7. Guatemalan human onchocerciasis. II. Evidence for IgG3 involvement in acquired immunity to Onchocerca volvulus and identification of possible immune-associated antigens.
Boyer AE; Tsang VC; Eberhard ML; Zea-Flores G; Hightower A; Pilcher JB; Zea-Flores R; Zhou W; Reimer CB
J Immunol; 1991 Jun; 146(11):4001-10. PubMed ID: 2033268
[TBL] [Abstract][Full Text] [Related]
8. Humoral responses to a secretory Onchocerca volvulus protein: differences in the pattern of antibody isotypes to recombinant Ov20/OvS1 in generalized and hyperreactive onchocerciasis.
Mpagi JL; Büttner DW; Tischendorf FW; Erttmann KD; Brattig NW
Parasite Immunol; 2000 Sep; 22(9):455-60. PubMed ID: 10972852
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an OV-16 IgG4 Enzyme-Linked Immunosorbent Assay in Humans and Its Application to Determine the Dynamics of Antibody Responses in a Non-Human Primate Model of
Cama VA; McDonald C; Arcury-Quandt A; Eberhard M; Jenks MH; Smith J; Feleke SM; Abanyie F; Thomson L; Wiegand RE; Cantey PT
Am J Trop Med Hyg; 2018 Oct; 99(4):1041-1048. PubMed ID: 30062989
[TBL] [Abstract][Full Text] [Related]
10. Resistance to Onchocerca volvulus: differential cellular and humoral responses to a recombinant antigen, OvMBP20/11.
Bradley JE; Elson L; Tree TI; Stewart G; Guderian R; Calvopiña M; Paredes W; Araujo E; Nutman TB
J Infect Dis; 1995 Sep; 172(3):831-7. PubMed ID: 7658078
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.
George PJ; Hess JA; Jain S; Patton JB; Zhan T; Tricoche N; Zhan B; Bottazzi ME; Hotez PJ; Abraham D; Lustigman S
PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007730. PubMed ID: 31525197
[TBL] [Abstract][Full Text] [Related]
12. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
[TBL] [Abstract][Full Text] [Related]
13. Analysis of IgG isotype responses against Onchocerca volvulus antigens in children in an onchocerciasis-endemic area in northern Nigeria.
Enwezor FN; Nock IH; Edeghere H; Idowu BT; Osue HO; Engelbrecht F
Ann Trop Paediatr; 2000 Jun; 20(2):141-6. PubMed ID: 10945066
[TBL] [Abstract][Full Text] [Related]
14. Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity.
MacDonald AJ; Turaga PS; Harmon-Brown C; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
Infect Immun; 2002 Jun; 70(6):2796-804. PubMed ID: 12010965
[TBL] [Abstract][Full Text] [Related]
15. The novel cuticular collagen Ovcol-1 of Onchocerca volvulus is preferentially recognized by immunoglobulin G3 from putatively immune individuals.
Stewart GR; Zhu Y; Parredes W; Tree TI; Guderian R; Bradley JE
Infect Immun; 1997 Jan; 65(1):164-70. PubMed ID: 8975907
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin G subclass responses of children during infection with Onchocerca volvulus.
Gbakima AA; Nutman TB; Bradley JE; McReynolds LA; Winget MD; Hong Y; Scott AL
Clin Diagn Lab Immunol; 1996 Jan; 3(1):98-104. PubMed ID: 8770512
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of IgG antibody responses to cloned Onchocerca volvulus antigens in microfiladermia positive individuals from Esmeraldas Province, Ecuador.
Trenholme KR; Tree TI; Gillespie AJ; Guderian R; Maizels RM; Bradley JE
Parasite Immunol; 1994 Apr; 16(4):201-9. PubMed ID: 8058358
[TBL] [Abstract][Full Text] [Related]
18. Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.
Turaga PS; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
Infect Immun; 2000 Apr; 68(4):1905-11. PubMed ID: 10722581
[TBL] [Abstract][Full Text] [Related]
19. Human isotype antibody responses to an Onchocerca volvulus glutathione S-transferase.
Salinas G; Sinha K; Cooper JP; Whitworth JA; Taylor DW
Parasite Immunol; 1996 Aug; 18(8):377-86. PubMed ID: 9229391
[TBL] [Abstract][Full Text] [Related]
20. Impaired antibody responses and loss of reactivity to Onchocerca volvulus antigens by HIV-seropositive onchocerciasis patients.
Tawill SA; Gallin M; Erttmann KD; Kipp W; Bamuhiiga J; Büttner DW
Trans R Soc Trop Med Hyg; 1996; 90(1):85-9. PubMed ID: 8730320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
